Back to all companies
Sign in
Back to all companies
NURX logo

NURX

Winter 2016Acquired

Medicine or testing kit, prescribed online and delivered to your door.

Save
NURX logo

NURX

Winter 2016Acquired

Medicine or testing kit, prescribed online and delivered to your door.

Save
Company details

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

Location
New York City, NY, USA; San Francisco, CA, USA
Founded
2016
Category
Consumer Health Services
YC Directory Pagewww.nurx.com
Founder
  • EE
    Edvard Engesaeth
    Founder
    X / TwitterLinkedIn

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

Location
New York City, NY, USA; San Francisco, CA, USA
Founded
2016
Category
Consumer Health Services
YC Directory Pagewww.nurx.com
Founder
  • EE
    Edvard Engesaeth
    Founder
    X / TwitterLinkedIn

Pressure-test this opportunity

Turn this teardown into a decision-ready prompt for ChatGPT, Claude, or your agent.

On this page
  • Overview
  • Founding Story
  • Timeline
  • What They Built
  • Market Position
  • Target customers
  • Market size
  • Competition
  • Business Model
  • Traction
  • Post-Mortem
  • An acquisition analysis, not an obituary
  • The distress countercase
  • What changed after the merger
  • Key Lessons
  • Sources

This report was generated by our Deep Research agent and may contain mistakes.

Did we get something wrong? DM @oscrhong and we'll fix it ASAP!

Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong
Exec Briefing

Actionable insights

If you only have a few minutes to spare, here’s what investors, operators, and founders should know about NURX (W16).

  1. A narrow wedge can hide broad operations. Nurx focused on contraception and sexual health, but every patient depended on clinical coverage, fulfillment, insurance, compliance, and follow-up.
  2. Distribution can become the asset. The Twirla collaboration shows that Nurx's patient relationship and prescribing workflow mattered to manufacturers, not only to patients.
  3. Consolidation can preserve product-market fit. Nurx continued as a brand inside Thirty Madison, suggesting the consumer wedge worked better on shared specialty-care infrastructure.
  4. Survival does not price the exit. Continued service proves customer value, but undisclosed consideration and standalone economics prevent a confident verdict on investor outcomes.

Overview

Nurx turned contraception and sexual-health care into a digital service: patients completed a health history online, received clinician review, and got medication or test kits delivered. Founded by Dr. Edvard Engesaeth and Hans Gangeskar and launched through Y Combinator in 2016, it later added migraine and dermatology care.[1][2]

This is not a failure story. Nurx proved that a politically sensitive, logistically awkward care category could support a durable consumer brand. Its 2022 merger with Thirty Madison shows the limit of the standalone model: clinical coverage, insurance, pharmacy operations, compliance, and patient acquisition become more economical when shared across conditions. Nurx survived as a brand because its wedge worked; the company consolidated because the infrastructure beneath that wedge rewarded scale.

Founding Story

Thirty Madison's merger announcement identifies Engesaeth and Gangeskar as the founders and says their aim was to remove barriers to essential care.[2] The company entered YC's Winter 2016 batch with a simple proposition: medicine and testing kits prescribed online and delivered to patients.[1] That framing mattered. Nurx did not begin as a general virtual clinic. It chose categories where privacy, convenience, recurring prescriptions, and uneven local access made an online front door unusually valuable.

The initial wedge was reproductive and sexual health, including contraception, STI testing, and HIV PrEP. Nurx later expanded into migraine and dermatology, with dermatology described as its fastest-growing service by the time of the merger.[2] The progression suggests a repeatable playbook: identify a condition with recurring treatment and access friction, then combine asynchronous intake, clinician review, fulfillment, and follow-up under one consumer brand.

The observed evidence does not establish the founders' detailed biographies, how they met, or the exact incident that produced the idea. It also contains no attributable full founder interview, so the canonical request for two verbatim founder quotations cannot be met honestly. The defensible founding story is narrower: two founders took a focused access problem through YC, proved the workflow in reproductive health, and broadened the operating model after the first wedge gained scale.

Timeline

  • 2016: Nurx launched through Y Combinator's Winter batch as an online prescription and delivery service.[1]
  • 2018: Axios placed Nurx among a growing group of direct-to-consumer birth-control companies, alongside Maven and The Pill Club, as Hers entered women's telehealth.[3]
  • By February 2022: Nurx had raised $110 million and expanded from reproductive and sexual health into migraine and dermatology.[2]
  • February 2022: Nurx and Thirty Madison announced a merger under the Thirty Madison brand. Nurx CEO Varsha Rao was to lead Nurx, while Steve Gutentag remained chief executive of the combined company.[2]
  • Fourth quarter 2022: Nurx and Agile Therapeutics launched a shared-marketing collaboration for the Twirla contraceptive patch.[4]
  • 2023: An Agile filing said The Pill Club had entered bankruptcy and Simple Health had ceased operations; Nurx was among the telehealth contraception businesses acquiring Pill Club assets.[4]
  • Current: Nurx identifies itself as a Thirty Madison company, with affiliated KMG medical groups providing consultations and secure messaging.[5]

What They Built

Nurx packaged several difficult tasks into one patient journey. A birth-control patient completes an online health-history consultation. A licensed provider reviews it, selects or approves treatment, and the service ships three months of medication. Automatic refills reduce interruption, while secure messaging gives the patient a route back to the medical team.[6]

The current service advertises more than 50 birth-control formulas, a $28 consultation, prices as low as $0 with insurance or $15 per month without it, discreet shipping, and controls to pause or cancel.[6] The product is therefore more than a video visit. Its value lies in coordinating intake, clinical decision-making, payment or insurance, fulfillment, refills, and longitudinal communication.

Unlock the full NURX teardown

Read the complete post-mortem, the rebuild playbook, and the exact reasons NURX is still worth studying now.

See Pro plans